Chairman's AGM Statement

AORTECH INTERNATIONAL PLC
26 August 1999


                      AGM STATEMENT
                            
At today's Annual General Meeting of AorTech
International plc, the Scottish-based manufacturer of
cardio-vascular devices, the Chairman, Gordon Wright,
made the following statement:

'Clearly we are going through a very exciting time in our
development.   The recent announcement  of  our  securing
rights  to the intellectual property, including  the  USA
patents,  for  TruCCOMS,  the innovative  new  Continuous
Cardiac Output Monitoring System, has been extremely well-
received.  We are delighted with that response.   We  are
making real progress towards regulatory approval for this
product  and  we believe that it will have a  significant
worldwide market.

'I  am  pleased  to  be able to report that  satisfactory
progress  continues in our core businesses.  In  summary,
these  are  the  manufacturing and selling  the  Ultracor
mechanical  valve and the new mitral repair  system,  the
sales and marketing of the Tissuemed valve together  with
the manufacturing of catheter components for Novoste Inc.

'Our new heart valve project is making good progress  and
remains  on  track.   In  my recent  statement  regarding
TruCCOMS  I  made  reference  to  our  Australian   joint
venture, Elastomedic, having signed evaluation agreements
with  five  major corporations.  We continue  to  believe
that   the   Elast-Eon  biomaterials  have  far  reaching
applications in a range of implant devices.

'As we said at the time of the fundraising we are looking
at  using  some  of  the funds to make  acquisitions.  We
expect to be in a position to make a further announcement
shortly.

'All in all we have real confidence in AorTech's exciting
new  technologies  and  their  future  potential  in  the
medical device market.'

Enquiries:

AorTech International plc          Tel: [phone]
Eddie McDaid, Managing Director

College Hill                       Tel: [phone]
Michael Padley